Flyer

Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 18
  • Journal CiteScore: 5.91
  • Journal Impact Factor: 4.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Articles published in Translational Biomedicine have been cited by esteemed scholars and scientists all around the world. Translational Biomedicine has got h-index 18, which means every article in Translational Biomedicine has got 18 average citations.

Following are the list of articles that have cited the articles published in Translational Biomedicine.

  2022 2021 2020 2019 2018

Total published articles

37 58 23 9 14

Conference proceedings

0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

195 200 233 230 237
Journal total citations count 1591
Journal impact factor 4.11
Journal 5 years impact factor 7.65
Journal cite score 5.91
Journal h-index 18
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Plaza JJ, Hulak N, Kausova G, Zhumadilov Z, Akilzhanova A (2016) Role of metabolism during viral infections, and crosstalk with the innate immune system. Intractable & rare diseases research 5: 90-96.
Ramma L, Sebothoma B (2016) The prevalence of hearing impairment within the Cape Town Metropolitan area. South African Journal of Communication Disorders 63: 1-10.
Srinivas CV, Shyamala V, Kumar BS (2016) Clinical study to evaluate the association between sensorineural hearing loss and diabetes mellitus in poorly controlled patients whose HbA1c> 8. Indian Journal of Otolaryngology and Head & Neck Surgery 68: 191-195.
Mahony JB, Bulir DC, Stone CB, inventors; Mcmaster University, assignee (2015) Type iii secretion injectisome proteins for treatment and prevention of chlamydial infections. United States patent application US 15/111,944.
Clayden RC (2012) CHARACTERIZATION OF CHLAMYDIA PNEUMONIAE CDSD AND ITS ROLE IN THE BASAL BODY OF THE TYPE III SECRETION APPARATUS (Doctoral dissertation).
Leighton TL (2012) Characterization of CopN (Cpn0324) the Putative Type III Secretion System Plug Protein of Chlamydia pneumoniae (Doctoral dissertation).
Australian Breastfeeding Association (2015) Topical treatment with breastmilk: randomised trials.
Abbaszadeh F, Hajizadeh Z, Jahangiri M (2016) Comparing the Impact of topical application of human milk and chlorhexidine on cord separation time in newborns. Pakistan journal of medical sciences 32: 239.
Abbaszadeh F, Atrian MK, Bagheri A, Sarafraz N (2014) Comparison of the effect of topical application of human milk and dry cord care on the bacterial colonization of umbilical cord in newborn infants. Journal of Kermanshah University of Medical Sciences (J Kermanshah Univ Med Sci) 18: 1-8.
Dionisio D (2011) Medicines Patent Pool: making the difference on access. Future Virology 6: 1147-1150.
Shahzad A, Williams LM, Lass-Flörl C, Shen A, Sami M (2012) MicroRNAs (miRNAs) In Virology: A Promising Transnational Research Approach. Transl Med 2: e110.
Vignola-Gagné E (2013) Gaps, Pitfalls and the Valley of Death.
Shahzad A, Cohrs RJ (2014) New horizons in translational medicine.
Vignola-Gagné E, Biegelbauer P, Lehner D (2014) Translational research: entrepreneurship, advocacy and programmatic work in the governance of biomedical innovation.
D'este P, Llopis O (2015) Connecting who? Balancing benefits and costs of sparse knowledge networks through gatekeepers.
Vignola-Gagné E, Biegelbauer P Daniel Lehner (2014) The Governance of Socio-Technical Systems: Explaining Change 28: 132.
Vignola-Gagné E (2014) Argumentative practices in science, technology and innovation policy: The case of clinician-scientists and translational research. Science and Public Policy 41: 94-106.
Vignola-Gagné E, Biegelbauer PS (2013) Translational research. InEncyclopedia of Creativity, Invention, Innovation and Entrepreneurship 2013 (pp. 1834-1843). Springer New York.
Abou-Gharbia M, Childers WE (2014) Discovery of innovative therapeutics: today’s realities and tomorrow’s vision. 2. Pharma’s challenges and their commitment to innovation. Journal of medicinal chemistry 57: 5525-5553.
Arthanari S, Ahmad H, Nisar M (2012) First reports of serious adverse drug reactions in recent weeks. Neurologist 18: 171-172.